Delivery Order SPE2DB24D1205-SPE2DB25FDABL
Award Date 9/3/25
Potential Completion Date 9/24/25
Potential Value $2.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Leqembi 200 mg/2 ml vials at a ceiling value of $1,048.38. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 5, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract does not utilize any set-aside designation, reflecting open competition...
- AmerisourceBergen Drug Corp has been awarded a delivery order contract by the Defense Logistics Agency (DLA) Medical Supply Chain for the supply of Leqembi 200 mg/2 mL vials. The contract, awarded on September 3, 2025, carries a ceiling value of $1,923.68 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 24, 2025. The award was made on a competitive basis with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Leqembi 500 mg/5 ml vials. This is a firm fixed-price delivery order with a ceiling value of $1,399.49 and a completion date of October 15, 2025. The contract was competitively awarded without set-aside designation to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, where the products will...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,136.57 for LEQEMBI 200 mg/2 ml vials by the Department of Defense Medical Supply Chain on July 21, 2025. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation. LEQEMBI is a specialized...
- The Defense Logistics Agency (DLA) awarded a $2,712.44 delivery order to AmerisourceBergen Drug Corp for Leqembi 500 mg/5 mL vials on August 13, 2025, with completion targeted for September 4, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,186.60 firm fixed-price contract is for the delivery of LEQEMBI 500 MG/5 ML VIAL 5ML, a medical supply product. The contract has an ultimate completion date of July 1, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,560.95 firm fixed-price delivery order is for the supply of LEQEMBI 500 MG/5 ML VIAL 5ML, a medication. The contract has an ultimate completion date of January 22, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- The Defense Logistics Agency awarded a delivery order valued at $2,325.55 to AmerisourceBergen Drug Corp for LEQVIO 284 mg/1.5 ml syringes on June 26, 2025, with an ultimate completion date of July 18, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Defense Department's Medical Supply Chain awarded a $1,574.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Leqembi 500 mg/5 mL vial, an FDA-approved monoclonal antibody treatment for early-stage Alzheimer's disease. The contract, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, represents a non-set-aside competitive award to the prime contractor's corporate office located in Conshohocken, Pennsylvania. This delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on June 18, 2025, by the Defense Logistics Agency (DLA) for the supply of LEQVIO 284 mg/1.5 mL syringes with a ceiling value of $16,278.85. This firm fixed-price delivery order, which is scheduled for completion by July 11, 2025, is unset-aside and competitively awarded. The award represents a continuation of the company's substantial role as a critical...